Press Release

Transcranial Magnetic Stimulation Market to Register a CAGR of 9% During Forecast Period

The Global Transcranial Magnetic Stimulation Market size was valued at around USD1.34 billion in 2024 and is projected to reach USD2.26 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The main reasons behind this growth are the increasing number of cases of brain disorders and the rising awareness among people regarding TMS therapies. As per the WHO, more than 1 billion people worldwide in 2023 have faced some kind of mental disorder. This has resulted in demand for TMS systems as various hospitals and clinics want to equip themselves with high-quality TMS systems.

The demand for TMS systems has been further fueled by insurance policies which tend to cover the cost of TMS therapies for the treatment of several mental disorders, like OCD and depression. This is common in countries such as the US, the Netherlands, and Australia. For instance, in Australia, TMS therapy was included in the Medical Benefits Schedule (MBS) in 2021, due to which major insurance companies cover the TMS treatment. Similar trends have been noticed in various other countries as well. As a result, it becomes important for the healthcare providers in this region to get themselves equipped with proper TMS systems, thus creating a high demand for such machinery.

Furthermore, there has been a rising prevalence of Parkinson’s disease, as around 90,000 cases are diagnosed annually in the US only. Additionally, this trend is further fueled by the increasing proportion of the elderly population, as this age group holds most such cases. For instance, around 96% of the cases are diagnosed in people aged above 50 years. Such cases increase the demand for TMS therapies, thus increasing their sales. Therefore, the rising number of cases of mental disorders, which is further fueled by the growing awareness among people has been the main reason behind the market’s growth, and this trend is expected to remain in the forecast period as well, further states the research report, “Global Transcranial Magnetic Stimulation Market Analysis, 2025.”

Global Transcranial Magnetic Stimulation Market Segmentation Analysis

Repetitive Transcranial Magnetic Stimulations Generating Massive Market Demand

Based on the type, the market is further bifurcated into Deep Transcranial Magnetic Stimulation (dTMS), Repetitive Transcranial Magnetic Stimulation (rTMS), and others. Here, the rTMS segment leads the market with a share of around 52%. The main reason behind this dominance is the traditional use of this segment, due to which it is easily accessible at multiple hospitals and clinics worldwide. Additionally, this method, unlike others, does not cause memory loss in the patients. Also, the risk of remission of disorders is very low with this treatment. For instance, less than 30% of patients face remission of symptoms when treated with rTMS, whereas this number was around 65% when treated with dTMS.

Moreover, all such advantages are assured along with minimal side effects. Therefore, this method is the safest and most precise one, due to which it has gained dominance, which is expected to remain in the future as well.

North America Dominates the Transcranial Magnetic Stimulation Industry Globally

Regionally, North America dominates the market with a market share of around 36%. The main reason behind this dominance is the high number of mental disorder patients in this region. For instance, around 21 million American adults faced depression disorders in 2023. Additionally, this growth is further fueled by the high disposable income of this region’s population and high awareness about the use of TMS therapies. As a result, the sales of TMS systems increase to align with the growing treatment demand. Moreover, leading market players established in this region and their high investments in research and development processes further fuel the growth of the market.

Therefore, due to high awareness and wide use of treatment, this region dominates the market, and this dominance is expected to continue in the future as well.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including BrainsWay, Magstim, Nexstim, Salience Health, MagVenture A/S, eNeura Inc., Neuronetics Inc., Neuromodec, Neurosoft, Seber Medical, Soterix Medical Inc., AXILUM ROBOTICS, MAG & More GmbH, and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the world?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across the regions?
6. How have buying behavior, customer inclination, and expectations from products been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?